tm logo
VONVENDI
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 19 May 2023

Last Applicant/ Owned by

1200 LAKESIDE DRIVE

BANNOCKBURN

IL

60015

Serial Number

86296063 filed on 30th May 2014

Registration Number

5095875 registered on 06th Dec 2016

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. Troutman Sanders LLP

c/o IP Services NYC

New York, NY 10022

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

VONVENDI

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF BLOOD DISORDERS; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF BLEEDING DISORDERS; AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF VON WILLEBRAND DISEASE

Classification Information


Class [005]
Pharmaceutical Products


PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF BLOOD DISORDERS; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF BLEEDING DISORDERS; AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF VON WILLEBRAND DISEASE


First Use Date in General

17th Aug 2016

First Use Date in Commerce

17th Aug 2016

Mark Details


Serial Number

No 86296063

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th May 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
19th May 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
19th May 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07th Nov 2022TEAS SECTION 8 & 15 RECEIVED
06th Dec 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06th Dec 2016REGISTERED-PRINCIPAL REGISTER
04th Nov 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03rd Nov 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03rd Nov 2016EXAMINER'S AMENDMENT ENTERED
03rd Nov 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED